Pulmonary embolism landmark trials: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==Landmark Clinical Trials== | ==Landmark Clinical Trials== | ||
===Trials assessing the diagnosis | ===Trials assessing the diagnosis=== | ||
1. '''PIOPED (Prospective Investigation in Pulmonary Embolism Diagnosis)''' (1989). | 1. '''PIOPED (Prospective Investigation in Pulmonary Embolism Diagnosis)''' (1989). | ||
* '''Purpose :''' To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism. | * '''Purpose :''' To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism. | ||
Revision as of 15:24, 10 January 2012
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism landmark trials On the Web |
|
Directions to Hospitals Treating Pulmonary embolism landmark trials |
|
Risk calculators and risk factors for Pulmonary embolism landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Ujjwal Rastogi, MBBS [2]
Landmark Clinical Trials
Trials assessing the diagnosis
1. PIOPED (Prospective Investigation in Pulmonary Embolism Diagnosis) (1989).
- Purpose : To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism.